高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Pharmaceutical industryinnovation an...

Mancuso, David A.

Pharmaceutical industryinnovation and developments /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmaceutical industry/ David A. Mancuso and Isobel M. Grenada, editors.
其他題名:	innovation and developments /
其他作者:	Mancuso, David A.
出版者:	Hauppauge, N.Y. :Nova Science, : c2011.,
面頁冊數:	1 online resource (ix, 182 p.) :ill. :
標題:	Drug development. -
電子資源:	http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=382402
ISBN:	9781621004394 (electronic bk.)

Pharmaceutical industryinnovation and developments /
Pharmaceutical industryinnovation and developments /[electronic resource] :David A. Mancuso and Isobel M. Grenada, editors. - Hauppauge, N.Y. :Nova Science,c2011. - 1 online resource (ix, 182 p.) :ill. - Business issues, competition and entrpreneurship. - Business issues, competition and entrepreneurship series..

Includes bibliographical references and index.

Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R & D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R & D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.

ISBN: 9781621004394 (electronic bk.)Subjects--Topical Terms:

232902
Drug development.
Index Terms--Genre/Form:

228523
Electronic books.

LC Class. No.: RM301.25 / P428 2011eb

Dewey Class. No.: 615/.19

National Library of Medicine Call No.: QV 736

Pharmaceutical industryinnovation and developments /
LDR:02284cam 2200385Ka 4500 001 248645
003 OCoLC
005 20120625232956.0
006 m d
007 cr cnu---unuuu
008 120712s2011 nyua ob 001 0 eng d
020 $a 9781621004394 (electronic bk.)
020 $a 1621004392 (electronic bk.)
020 $z 9781612093949
020 $z 1612093949
035 $a (OCoLC)750642412
035 $a ocn750642412
040 $a N$T $b eng $c N$T $d OCLCQ
049 $a KMCA
050 4 $a RM301.25 $b P428 2011eb
060 4 $a QV 736
072 7 $a MED $x 023000 $2 bisacsh
072 7 $a MED $x 058170 $2 bisacsh
072 7 $a MED $x 071000 $2 bisacsh
072 7 $a MED $x 072000 $2 bisacsh
082 0 4 $a 615/.19 $2 22
245 0 0 $a Pharmaceutical industry $h [electronic resource] : $b innovation and developments / $c David A. Mancuso and Isobel M. Grenada, editors.
260 $a Hauppauge, N.Y. : $c c2011. $b Nova Science,
300 $a 1 online resource (ix, 182 p.) : $b ill.
490 1 $a Business issues, competition and entrpreneurship
504 $a Includes bibliographical references and index.
505 0 $a Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R & D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R & D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
588 $a Description based on print version record.
650 0 $2 96060 $a Drug development. $3 232902
650 0 $2 96060 $a Pharmaceutical industry. $3 253879
650 0 $a Drugs $x Law and legislation. $3 310608
650 2 $a Drug Industry $x economics. $3 322651
650 2 $a Drug Industry $x legislation & jurisprudence. $3 311172
650 2 $a Drug Discovery $x economics. $3 322652
650 2 $a Drugs, Generic $x economics. $3 322653
650 7 $a MEDICAL $x Drug Guides. $2 bisacsh $3 322588
650 7 $a MEDICAL $x Nursing $x Pharmacology. $2 bisacsh $3 322591
650 7 $a MEDICAL $x Pharmacology. $2 bisacsh $3 322589
650 7 $a MEDICAL $x Pharmacy. $2 bisacsh $3 322590
655 4 $a Electronic books. $2 local $3 228523
700 1 $a Mancuso, David A. $3 322648
700 1 $a Grenada, Isobel M. $3 322649
830 0 $a Business issues, competition and entrepreneurship series. $3 322650
856 4 0 $3 EBSCOhost $u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=382402
994 $a 92 $b KMC
999 $z 634762210347752051

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別